Episode description
This show was recorded 21 September 2023 and can be viewed on our website here. To join us live for future shows and ask your own questions, please view and sign up for upcoming events in our Knowledge Center. Thank you for tuning in! 🙏
We all know: ensuring the safety and efficacy of medical devices is critical to protecting patients and minimizing risks to healthcare providers.
One of the key challenges in achieving this goal is selecting and managing materials effectively, while maintaining supplier controls and identifying opportunities for proactive design changes.
In this panel discussion, experts in medical device development, regulatory compliance, and material science will share their insights on navigating material risks and implementing strategies to improve medical device safety.
Topics will include:
- Best practices for material selection and supplier controls in medical device development
- Strategies for proactive risk management, including early identification and mitigation of material-related risks
- Approaches to biocompatibility testing and regulatory compliance in medical device development
- The changing landscape of medical device regulation and its impact on material selection and supplier controls
- Case studies and practical examples of effective material risk management in medical device development
Attendees will come away from this session with a better understanding of how to navigate material risks in medical device development and implement effective strategies for improving safety and quality.
Panelists
- Jaishankar (Jai) Kutty, Ph.D. – Vice President, Intelligence & Innovation, RQM+
- Kevin Rowland – Director of R&D, RQM+
- Taryn Meade – Director of Biological Evaluation Consulting, RQM+
- Christine Santagate – Chief of Staff, Lab Services (moderator)
--
📲 Follow RQM+ on LinkedIn.
💼 Check out our open positions.
📚 See on-demand content in our Knowledge Center.
📝 If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use our contact form.